CellSource Co., Ltd. (4880.T)

1.375,00 +103,00 (+8,10%) Börsenschluss: 03:00PM JST

CellSource Co., Ltd.

SHIBUYA CAST.
11th Floor 23-21 Shibuya 1-chome Shibuya-ku
Tokyo 150-0002
Japan
81 3 6455 5308
https://www.cellsource.co.jp

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 151

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Masayuki Yamakawa M.D.	Executive Chairman & MD	N/A	N/A	1964
Mr. Takashi Sawada	Representative Director, President & CEO	N/A	N/A	1957
Mr. Katsuji Onishi	Executive Officer, GM of Mgt. HQ., Head of Mgt. HQ. & GM of Administration	N/A	N/A	1971
Mr. Masato Tsumamoto	CXO, Chief Transformation Officer & Representative Director	N/A	N/A	1982
Mr. Hirohiko Hanaki	Executive Officer & Head of Medical Affairs Headquarters	N/A	N/A	1969
Kaoru Hosoda	Executive Officer & Head of Corporate Planning Headquarters	N/A	N/A	N/A
Mr. Futa Asada	Executive Officer, Head of CPC Headquarters & Director	N/A	N/A	1988

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in JPY.

Beschreibung

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy, as well as manufacturing processed cells. It is also involved in the development and sale of Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Corporate Governance

CellSource Co., Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.